A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
Contrast medium is frequently associated with allergic reactions and kidney dysfunction. However, contrast media can induce hemolytic anemia with a broad spectrum of hemolytic manifestations. We report a 38-year-old patient with very severe immune hemolytic anemia after the application of iomeprol d...
Saved in:
Main Authors: | Sabine Hermann, Karina Althaus, Migdat Mustafi, Beate Mayer, Peter Rosenberger, Helene Anna Haeberle, Alice Bernard |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1464014/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eculizumab treatment for Chinese patients with hemolytic paroxysmal nocturnal hemoglobinuria (PNH): efficacy and safety – a single-center study
by: Leyu Wang, et al.
Published: (2025-12-01) -
The endocannabinoid system’s genetic polymorphisms in sickle cell anemia patients
by: Amanda Cristina Meneguetti Berti, et al.
Published: (2024-12-01) -
Plasmapheresis for extracorporeal membrane oxygenation (ECMO)-induced hemolysis in infants
by: Budhu Gail, et al.
Published: (2024-12-01) -
Preanalitik Numune Ret Analizi ve Hemşirelere Dijital Platform Üzerinden Yapılan Eğitimin Etkisi
by: Neslihan Yılmaz, et al.
Published: (2021-12-01) -
How we prevented an anti-P1 mediated hemolytic transfusion reaction
by: Beatrice Borsellino, et al.
Published: (2024-01-01)